Biological and clinical aspects of prolactin receptors (PRL-R) in human breast cancer
- 20 December 1990
- journal article
- clinical trial
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 37 (6) , 977-981
- https://doi.org/10.1016/0960-0760(90)90453-r
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Tamoxifen plus bromocriptine versus tamoxifen plus placebo in advanced breast cancer: Results of a double blind multicentre clinical trialEuropean Journal of Cancer and Clinical Oncology, 1988
- Correlation between prolactin receptors (PRL R), estradiol (ER) and progesterone receptors (PgR) in human breast cancerEuropean Journal of Cancer and Clinical Oncology, 1986
- Regulation of growth hormone and epidermal growth factor receptors by progestins in breast cancer cellsBiochemical and Biophysical Research Communications, 1985
- Characterization of prolactin receptors in human breast cancerBreast Cancer Research and Treatment, 1984
- Effect of bromocriptin treatment on prolactin and steroid receptor levels in human breast cancerEuropean Journal of Cancer and Clinical Oncology, 1984
- The localization of prolactin binding sites in human breast tissueInternational Journal of Cancer, 1983
- Prolactin binding by human mammary carcinoma: Relationship to estrogen receptor protein concentration and patient ageBreast Cancer Research and Treatment, 1981
- Prolactin receptors in human breast carcinomaCancer, 1979
- PROLACTIN DEPENDENCE IN HUMAN BREAST CANCERSThe Lancet, 1972
- Clinical trial of 2-Br-α-ergocryptine (CB154) in advanced breast cancerPublished by Elsevier ,1972